Curcumin and neurological diseases.
Raffaella AdamiDaniele BottaiPublished in: Nutritional neuroscience (2020)
Objectives: The beneficial effects of many substances have been discovered because of regular dietary consumption. This is also the case with curcumin, whose effects have been known for more than 4,000 years in Eastern countries such as China and India. A curcumin-rich diet has been known to counteract many human diseases, including cancer and diabetes, and has been shown to reduce inflammation. The effect of a curcumin treatment for neurological diseases, such as spinal muscular atrophy; Alzheimer's disease; Parkinson's disease; amyotrophic lateral sclerosis; multiple sclerosis; and others, has only recently been brought to the attention of researchers and the wider population.Methods: In this paper, we summarise the studies on this natural product, from its isolation two centuries ago to its characterisation a century later.Results: We describe its role in the treatment of neurological diseases, including its cellular and common molecular mechanisms, and we report on the clinical trials of curcumin with healthy people and patients.Discussion: Commenting on the different approaches adopted by the efforts made to increase its bioavailability.
Keyphrases
- multiple sclerosis
- amyotrophic lateral sclerosis
- clinical trial
- end stage renal disease
- type diabetes
- endothelial cells
- chronic kidney disease
- oxidative stress
- cardiovascular disease
- newly diagnosed
- physical activity
- squamous cell carcinoma
- cognitive decline
- prognostic factors
- randomized controlled trial
- combination therapy
- papillary thyroid
- young adults
- patient reported outcomes
- replacement therapy
- phase ii